Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMB5 | P28074 | 1/20 | 0.51 |
| ▸ | REN | P00797 | 2/20 | 0.49 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.49 |
| ▸ | NPY4R | P50391 | 9/20 | 0.48 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.48 |
| ▸ | NPY1R | P25929 | 7/20 | 0.48 |
| ▸ | NPY2R | P49146 | 4/20 | 0.48 |
| ▸ | CTSB | P07858 | 1/20 | 0.47 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4325541 | 1.00 | PSMB5 (0.51) | PSMB5RENFOLH1NPY4RNPY5R | |
| SCHEMBL29885010 | 0.89 | GRIA1 (0.53) | PSMB5 | |
| Tyropeptin A SCHEMBL29843181 | 0.88 | CASP1 (0.50) | PSMB5RENCTSB | |
| Tyropeptin A SCHEMBL2808523 | 0.88 | CASP1 (0.50) | PSMB5RENCTSB | |
| Tyropeptin A SCHEMBL2808528 | 0.88 | CASP1 (0.50) | PSMB5RENCTSB | |
| SCHEMBL25627902 | 0.86 | CTSB (0.49) | PSMB5FOLH1NPY4RNPY5RNPY1R | |
| SCHEMBL24178166 | 0.85 | CTSB (0.56) | PSMB5FOLH1CTSBOPRM1OPRD1 | |
| SCHEMBL31010534 | 0.84 | CTSD (0.54) | PSMB5RENCTSB | |
| SCHEMBL9219464 | 0.84 | CTSD (0.54) | PSMB5RENCTSB | |
| SCHEMBL29361872 | 0.84 | NPY4R (0.51) | FOLH1NPY4RNPY5RNPY1RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023067380-A1 | GENETIC SYSTEM FOR THE BIOSYNTHESIS OF LEUPEPTIN AND USE THEREOF IN HETEROLOGOUS PRODUCTION SYSTEMS | CENTRO DE INVESTIGACIÓN Y DE ESTUDIOS AVANZADOS DEL INSTITUTO POLITÉCNICO NACIONAL (MX) | 2023-04-27 | — | — | WO | disclosed |
| CN-108379591-B | Synthesis of immune agonist targeting compound and application thereof | 深圳大学 | 2022-03-29 | — | — | CN | disclosed |
| EP-2061518-A2 | RADIOIMAGING MOIETIES COUPLED TO PEPTIDASE-BINDING MOIETIES FOR IMAGING TISSUES AND ORGANS THAT EXPRESS PEPTIDASES | Molecular Insight Pharmaceuticals, Inc. (US) | 2009-05-27 | — | — | EP | disclosed |
| US-20080213172-A1 | RADIOIMAGING MOIETIES COUPLED TO PEPTIDEASE-BINDING MOIETIES FOR IMAGING TISSUES AND ORGANS THAT EXPRESS PEPTIDASES | MOLECULAR INSIGHT PHARMACEUTICALS, INC. | 2008-09-04 | — | — | US | disclosed |
| WO-2008028000-A2 | RADIOIMAGING MOIETIES COUPLED TO PEPTIDASE-BINDING MOIETIES FOR IMAGING TISSUES AND ORGANS THAT EXPRESS PEPTIDASES | MOLECULAR INSIGHT PHARMACEUTICALS, INC. (US) | 2008-03-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080213172-A1 | RADIOIMAGING MOIETIES COUPLED TO PEPTIDEASE-BINDING MOIETIES FOR IMAGING TISSUES AND ORGANS THAT EXPRESS PEPTIDASES | LAP3, DNPEP, ACE | PSMB5 2185/4885REN 41/4885FOLH1 95/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.